These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22891343)

  • 1. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections.
    Lai BS; Witola WH; El Bissati K; Zhou Y; Mui E; Fomovska A; McLeod R
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14182-7. PubMed ID: 22891343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice.
    Azimi-Resketi M; Eskandarian A; Ganjalikhani-Hakemi M; Zohrabi T
    Acta Trop; 2020 Jul; 207():105488. PubMed ID: 32277926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of antimicrobials into parasites.
    Samuel BU; Hearn B; Mack D; Wender P; Rothbard J; Kirisits MJ; Mui E; Wernimont S; Roberts CW; Muench SP; Rice DW; Prigge ST; Law AB; McLeod R
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14281-6. PubMed ID: 14623959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
    Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion.
    Skariah S; McIntyre MK; Mordue DG
    Parasitol Res; 2010 Jul; 107(2):253-60. PubMed ID: 20514494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
    Afanador GA; Muench SP; McPhillie M; Fomovska A; Schön A; Zhou Y; Cheng G; Stec J; Freundlich JS; Shieh HM; Anderson JW; Jacobus DP; Fidock DA; Kozikowski AP; Fishwick CW; Rice DW; Freire E; McLeod R; Prigge ST
    Biochemistry; 2013 Dec; 52(51):9155-66. PubMed ID: 24295325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts.
    Ferreira-da-Silva Mda F; Takács AC; Barbosa HS; Gross U; Lüder CG
    Int J Med Microbiol; 2009 Jun; 299(5):381-8. PubMed ID: 19097936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative strategy to increasing influenza virus replication for vaccine production in chicken embryo fibroblast (DF-1) cells by inhibiting interferon alpha and beta using peptide-conjugated phosphorodiamidate morpholino oligomers.
    Prescott MA; Moulton H; Pastey MK
    J Med Microbiol; 2024 Feb; 73(2):. PubMed ID: 38353513
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of stage interconversion in vitro and in vivo by construction of transgenic Toxoplasma gondii that stably express stage-specific fluorescent proteins.
    Zhang H; Zhang Y; Cao J; Zhou Y; Wang N; Zhou J
    Exp Parasitol; 2013 Jul; 134(3):275-80. PubMed ID: 23545429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
    Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Profiling Suggests T Cells Cluster around Neurons Injected with Toxoplasma gondii Proteins.
    Merritt EF; Johnson HJ; Wong ZS; Buntzman AS; Conklin AC; Cabral CM; Romanoski CE; Boyle JP; Koshy AA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878927
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular docking to Toxoplasma gondii thymidylate synthase-dihydrofolate reductase and efficacy of raltitrexed in infected mice.
    de Paula Reis M; de Lima DA; Pauli KB; Andreotti CEL; de Moraes ALS; Gonçalves DD; Navarro IT; Bueno PSA; Seixas FAV; Gasparotto Junior A; Lourenço ELB
    Parasitol Res; 2018 May; 117(5):1465-1471. PubMed ID: 29550996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development.
    Sugi T; Ma YF; Tomita T; Murakoshi F; Eaton MS; Yakubu R; Han B; Tu V; Kato K; Kawazu S; Gupta N; Suvorova ES; White MW; Kim K; Weiss LM
    mBio; 2016 May; 7(3):. PubMed ID: 27247232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin Cs are key for the intracellular survival of the protozoan parasite, Toxoplasma gondii.
    Que X; Engel JC; Ferguson D; Wunderlich A; Tomavo S; Reed SL
    J Biol Chem; 2007 Feb; 282(7):4994-5003. PubMed ID: 17164247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
    Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
    [No Abstract]   [Full Text] [Related]  

  • 17. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.
    Greenberg DE; Marshall-Batty KR; Brinster LR; Zarember KA; Shaw PA; Mellbye BL; Iversen PL; Holland SM; Geller BL
    J Infect Dis; 2010 Jun; 201(12):1822-30. PubMed ID: 20438352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachyzoite-specific isoform of Toxoplasma gondii lactate dehydrogenase is the target antigen of a murine CD4(+) T-cell clone.
    Reichmann G; Długońska H; Hiszczyńska-Sawicka E; Fischer H
    Microbes Infect; 2001 Aug; 3(10):779-87. PubMed ID: 11580972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
    Rosenke K; Leventhal S; Moulton HM; Hatlevig S; Hawman D; Feldmann H; Stein DA
    J Antimicrob Chemother; 2021 Jan; 76(2):413-417. PubMed ID: 33164048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.
    Howard JJ; Sturge CR; Moustafa DA; Daly SM; Marshall-Batty KR; Felder CF; Zamora D; Yabe-Gill M; Labandeira-Rey M; Bailey SM; Wong M; Goldberg JB; Geller BL; Greenberg DE
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.